Molecular Imaging: Page 323

Mirada nets MD Anderson contract

By AuntMinnie.com staff writers

Medical imaging software developer Mirada Medical announced it has been selected to deliver its XD3 image review and analysis software to the University of Texas MD Anderson Cancer Center in Houston.

November 26, 2011

FDG-PET/CT assesses early chemo response in breast cancer

By Wayne Forrest

CHICAGO - FDG-PET/CT's ability to evaluate pathological response after two cycles of neoadjuvant chemotherapy could help breast cancer patients avoid ineffective treatment, according to a study presented on Sunday at the RSNA 2011 meeting.

November 26, 2011

Siemens offers radiation website for general public

By AuntMinnie.com staff writers

Siemens Healthcare has launched a new information website for patients facing an x-ray or a nuclear medicine exam. At www.medicalradiation.com, scientific journalists and experts from Siemens provide basic details about medical radiation for patients and interested members of the general public.

November 26, 2011

Gadolinium oxide nanoparticles enhance MRI contrast

By Luc Faucher

Ultrasmall gadolinium oxide nanoparticles provide strong positive contrast enhancement at clinical magnetic field strengths. For this reason, they are being developed as positive contrast agents for molecular and cellular MRI.

November 23, 2011

Gamma camera market faces PET threat

By AuntMinnie.com staff writers

While the global gamma scintillation camera market is increasing due to more periodic diagnostic tests, the rising popularity of PET procedures may threaten that growth in traditional imaging areas, according to a new report from market research firm Global Industry Analysts.

November 21, 2011

IBA grows sales in Q3

By AuntMinnie.com staff writers

Gains in its proton therapy segment offset a decline in dosimetry products to grow revenues for radiopharmaceutical developer Ion Beam Applications (IBA) in the third quarter.

November 21, 2011

Manhattan Isotope inks cyclotron agreement

By AuntMinnie.com staff writers

Manhattan Isotope Technology, with the support of molecular imaging developer Positron, has signed a memorandum of understanding with the ARRONAX cyclotron facility in Nantes, France, that will allow the firms to collaborate on the production of strontium-82 and other medical radionuclides.

November 16, 2011

ASL-MRI may have edge over FDG-PET for Alzheimer's

By Wayne Forrest

Researchers have found that MRI with an arterial spin labeling (ASL) technique is a promising alternative to FDG-PET for tracking and diagnosing Alzheimer's disease, according to studies published online November 16 in Alzheimer's and Dementia and Neurology.

November 16, 2011

Image Gently, SNM launch guidelines campaign

By AuntMinnie.com staff writers

The Image Gently campaign and the Society of Nuclear Medicine (SNM) have launched a new campaign called "Go With the Guidelines" to encourage community hospitals, academic hospitals, and clinics to observe new guidelines for administering radiopharmaceuticals in children.

November 15, 2011

Covidien ends fiscal 2011 with sales gains

By AuntMinnie.com staff writers

Healthcare technology firm Covidien is crediting new product launches and market share gains in several categories for double-digit growth in net sales in fiscal year 2011.

November 15, 2011

Int'l Isotopes' revenues up 25% in Q3

By AuntMinnie.com staff writers

Increased revenue in its radiochemical products and nuclear medicine standards segments powered radioisotope manufacturer International Isotopes to double-digit growth in the first nine months of 2011.

November 14, 2011

Global radiopharma market could top $6B by 2017

By AuntMinnie.com staff writers

The global radiopharmaceuticals market could reach $6.63 billion by 2017, according to a report from market research firm Global Industry Analysts.

November 14, 2011

Previous Page

Page 323 of 620

Next Page